Switch to: References

Add citations

You must login to add citations.
  1. Die zeitliche Dimension des Broad Consent.Svenja Wiertz - 2022 - Ethik in der Medizin 34 (4):645-667.
    Zusammenfassung Die informierte Einwilligung von Teilnehmer:innen gilt in vielen Fällen als Voraussetzung auch für die rein datenbasierte medizinische Forschung. In diesem Kontext wird ein Modell der breiten Einwilligung (_Broad Consent_) diskutiert. In Deutschland hat die Medizininformatik-Initiative einen konkreten Vorschlag für deutsche Kliniken ausgearbeitet, der eine Gültigkeit der Einwilligung für einen Zeitraum von 30 Jahren vorsieht. Der vorliegende Artikel diskutiert vor diesem Hintergrund die Frage, wie der Anspruch der Informiertheit in dieser zeitlichen Perspektive einzuordnen ist. Die Praxis der Einwilligung wird dabei (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • The temporal dimension of broad consent.Svenja Wiertz - 2022 - Ethik in der Medizin 34 (4):645-667.
    ContextIn many cases, informed consent of participants is considered a prerequisite even for exclusively data-based medical research. In this context, a model of broad consent is being discussed. In Germany, the Medizininformatik-Initiative (Medical Informatics Initiative) has developed a proposal for broad consent for German hospitals which suggests a validity period of 30 years.Definition of the problemAgainst this background, the article discusses how the claim of consent beinginformedhas to be regarded in a temporal perspective. The practice of consent is here understood (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Authority and the Future of Consent in Population-Level Biomedical Research.Mark Sheehan, Rachel Thompson, Jon Fistein, Jim Davies, Michael Dunn, Michael Parker, Julian Savulescu & Kerrie Woods - forthcoming - Public Health Ethics.
    Population-level biomedical research has become crucial to the health system’s ability to improve the health of the population. This form of research raises a number of well-documented ethical concerns, perhaps the most significant of which is the inability of the researcher to obtain fully informed specific consent from participants. Two proposed technical solutions to this problem of consent in large-scale biomedical research that have become increasingly popular are meta-consent and dynamic consent. We critically examine the ethical and practical credentials of (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.Marlies Saelaert, Heidi Mertes, Tania Moerenhout, Elfride De Baere & Ignaas Devisch - 2020 - BMC Medical Ethics 21 (1):1-12.
    Incidental findings and secondary findings, being results that are unrelated to the diagnostic question, are the subject of an important debate in the practice of clinical genomic medicine. Arguments for reporting these results or not doing so typically relate to the principles of autonomy, non-maleficence and beneficence. However, these principles frequently conflict and are insufficient by themselves to come to a conclusion. This study investigates empirically how ethical principles are considered when actually reporting IFs or SFs and how value conflicts (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Differences in Conceptual Understanding of the “Actionability” of Incidental Findings and the Resultant Difference in Ethical Responsibility: An Empirical Study in Japan.Tomohide Ibuki, Keiichiro Yamamoto & Kenji Matsui - 2020 - AJOB Empirical Bioethics 11 (3):187-194.
    Download  
     
    Export citation  
     
    Bookmark  
  • Ubuntu philosophy and the consensus regarding incidental findings in genomic research: a heuristic approach.Cornelius Ewuoso - 2020 - Medicine, Health Care and Philosophy 23 (3):433-444.
    This study adopts a heuristic technique to argue the thesis that a set of norms rooted in the African philosophy of Ubuntu can usefully supplement current research guidelines for dealing with incidental findings discovered in genomic research. The consensus regarding incidental findings is that there is an ethical obligation to return individual genetic incidental findings that meet the threshold of analytic and clinical validity, have clinical utility, and are actionable, provided that research contributors have not opted out from receiving such (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Shining a Light also Casts a Shadow: Neuroimaging Incidental Findings in Neuromarketing Research.Owen M. Bradfield - 2021 - Neuroethics 14 (3):459-465.
    Rapid growth in structural and functional brain research has led to increasing ethical discussion of what to do about incidental findings within the brains of healthy neuroimaging research participants that have potential health importance, but which are beyond the original aims of the study. This dilemma has been widely debated with respect to general neuroimaging research but has attracted little attention in the context of neuromarketing studies. In this paper, I argue that neuromarketing researchers owe participants the same ethical obligations (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations